CUBE vs XFOR · P/E 25, rev $1.07B vs rev $6.5M
CubeSmart (CUBE) versus X4 Pharmaceuticals Inc (XFOR) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
X4 Pharmaceuticals Inc (XFOR) is a biotechnology company listed on NASDAQ.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported XFOR revenue for 2025-12-31 was $6.5M. Net income was -$79.2M. Revenue was up 154.2% from 2024-12-31 to 2025-12-31. XFOR currently screens at market cap $382.0M.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. XFOR currently screens at market cap $382.0M.
Not investment advice. Open the CUBE and XFOR stock pages for the full models.
Not investment advice.